ABEO Abeona Therapeutics
- 4.1000
- +0.0400+0.99%
- 4.1600
- +0.0600+1.46%
Abeona Therapeutics News
Abeona Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Alland Leila
Abeona Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Abeona Therapeutics | 10-Q: Quarterly report
Abeona Therapeutics | 8-K: Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress
Abeona Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Suvretta Capital Management, LLC(9.3%),Aaron Cowen(9.3%), etc.
Abeona Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Janus Henderson Group plc(6.1%),Janus Henderson Biotech Innovation Master Fund Ltd(6.1%)
Abeona Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Adage Capital Management, L.P.
Abeona Therapeutics | 8-K: Current report
Abeona Therapeutics | 424B5: Prospectus
Abeona Therapeutics | 8-K: Current report
Abeona Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Seshadri Vishwas
Abeona Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Charles Faith L.
Abeona Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer O'Malley Brendan M.
Abeona Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Vazzano Joseph Walter
Abeona Therapeutics | 8-K: Current report
Abeona Therapeutics | 8-K: Current report
Abeona Therapeutics | DEF 14A: Definitive information statements
Abeona Therapeutics | 8-K: Current report
Abeona Therapeutics | 10-K: Annual report
Abeona Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Vazzano Joseph Walter
Analysis
Price Target
No Data
